Turbocharging is playing a pivotal role in the UK’s shift toward hybrid internal combustion engines (ICEs). As fully electric ...
Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at Increased Dose LevelsPatients are Now Be ...
This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...
Aptose Biosciences Inc. Net loss for the quarter ended September 30, 2025 decreased by $1.8 million to $5.1 million, as compared to $7.0 million for the comparable period in 2024. Net loss for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback